Recent Advances in Cardiac Repair and Regeneration
A special issue of Cells (ISSN 2073-4409).
Deadline for manuscript submissions: closed (15 October 2023) | Viewed by 2272
Special Issue Editor
Special Issue Information
Dear Colleagues,
Despite the dramatic progression of available pharmacological therapies for the management of cardiovascular disease, the latter remains the major cause of death and disability worldwide. Damage irreversibility, myocardial remodeling process and inability to replace the dead cardiomyocytes constitute the main limitations of current invasive and non-invasive therapeutic approaches for cardiac diseases. Thus, restoring a normal myocardial function is a challenge for researchers. Reparative and regenerative medicine seems a promising therapy that may offer survival benefit for millions of people. It includes stem cells, extracellular vesicles, genetic modifications and bioactive factors with scaffolds made up of biodegradable and biocompatible materials. It is essential to consider both pathophysiological and immunomodulatory properties for evaluating their applicability in cardiac tissue repair and regeneration. This special issue provides a potential platform for publications on pathophysiology, pharmacological approach, biotherapies including stem cells and gene therapies in addition to biomaterial-based tissue (engineered cardiac patches) in the setting of cardiac repair and regeneration.
Prof. Dr. Jerome Roncalli
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiac repair
- cardiac regeneration
- biotherapy
- cell therapy
- gene therapy
